1,339 results on '"Kakkar V"'
Search Results
2. POS0425 SUBCLINICAL LOSS OF LUNG VOLUMES IN VERY EARLY SSc: EVIDENCE FROM THE VEDOSS DATABASE
3. OP0314 INTERFERON SCORE AS A NOVEL TRIAL ENRICHMENT TOOL TO PREDICT CLINICAL OUTCOMES IN PATIENTS WITH LIMITED CUTANEOUS SYSTEMIC SCLEROSIS
4. AB0881 CLINICAL TRAJECTORIES OF MULTIFACTORIAL HAND FUNCTION DETERIORATION IN SYSTEMIC SCLEROSIS
5. WCN23-0071 CYTOKINE ADSORBING COLUMN IN SEVERE COVID-19 PATIENTS WITH ACUTE KIDNEY INJURY
6. Genetic epidemiology of coronary artery disease: an Asian Indian perspective
7. POS0876 SERUM INTERFERON SCORE PREDICTS SEVERITY OF PATIENT REPORTED HAND DISABILITY IN SYSTEMIC SCLEROSIS
8. The Use of Isosteric Bonds in the Design of Thrombin Inhibitors
9. Gene centric analysis combined with network analysis to identify genes associated with coronary artery disease: OR010
10. Tolerance to multiantigenic molecule expressing peptides from APOB100, HSP60 and outer membrane protein of chlamydia pneumonia reduces markers of plaque instability and stabilizes advanced atherosclerosis in APOBTM2SGY/LDLRTM1HER/J mice: OR008
11. Swapping over two peptide epitopes derived from APOB and C5AR located at terminuses of recombinant proteins maintains the similar effective reduction on atherosclerotic lesion in B6;129S-LDLR(TM1HER) APOB(TM2SGY)/J mice: OR006
12. The I125-Labeled Fibrinogen Test and Phlebography in the Diagnosis of Deep Vein Thrombosis
13. POS0319 PERFORMANCE OF PATIENT REPORTED OUTCOMES (PROs) IN SCLERODERMA PATIENTS WITH REDUCED LUNG FUNCTION IN AN OBSERVATIONAL COHORT
14. 14 Orthopaedic Post-Operative Elective Proforma
15. Non-invasive assessment of extent of atherosclerotic disease, CVD risk factors and atherothrombotic biomarkers in Asian Indians: PO 476
16. Non-invasive surrogate markers of coronary artery disease in Asian Indians: PO 475
17. Improvement of risk assessment with multi-pathway representative markers for coronary artery disease in the indian population: PO 480
18. Immunization With A Peptide Containing Two Epitopes Derived From Chlamydia Pneumoniae (Cpn) Significantly Reduces Atherosclerotic Lesion In Apobtm2SgyLdlrtm1Her/J Mice Infected With The Cpn Bacteria: PO 470
19. A comprehensive genetic analysis of the 9p21.3 CAD risk locus in Asian Indians: PO 478
20. Association of periodontal disease, extent of peripheral vascular changes, oral pathogens and risk of coronary artery disease in Asian Indians: PO 477
21. A genetic risk score for coronary artery disease in Asian Indians: PO 474
22. Mucosal Tolerance to Multiple Peptides Ameliorates Atherosclerosis in Rabbits: PO 473
23. Association of serum gamma-glutamyl transferase (GGT) and other markers with extent of coronary artery disease in angiographically proven patients and its potential use as risk indicator: PO 471
24. Urinary Biomarker discovery for coronary artery disease risk prediction using global proteomic analysis: PB 4.32–6
25. Association of obesity markers and atherothrombotic biomarkers in coronary artery disease: PB 4.32–1
26. Comprehensive analysis of global gene expression and microRNA profile in coronary artery disease: PB 4.31–6
27. Can we identify patients at risk of recurrent coronary artery disease?: PB 4.31–1
28. Diet modification in conjunction with regulatory immune response to a combination of ApoB and HSP60 peptides controls progression of atherosclerotic lesions in Apobtm2Sgy Ldlrtm1Her/J mice: PB 3.71–3
29. Immunological tolerance to a combination of ApoB and HSP60 peptides decreases markers known to be associated with plaque instability in mice model of atherosclerosis: PB 3.32–6
30. Novel network biomarkers profile based coronary artery disease risk stratification in Asian Indians: PB 3.32–1
31. Integrative bioinformatics analysis of genomic and proteomic approaches to understand the transcriptional regulatory program in coronary artery disease pathways: PB 1.73–3
32. Replacement of Apob peptide sequence with C5ar peptide sequence in a recombinant vaccine construct significantly increases the atheroprotective effect of immunization in Apobtm2SgyLdlrtm1Her/J mouse: PB 1.32–2
33. Oral administration of recombinant multi antigenic construct expressing three peptides induces tolerance to individual peptides and prevents development of atherosclerosis in mice: PB 1.32–4
34. Immunization with a linear peptide derived from tissue factor and protease activated receptor-1 significantly reduces the development of atherosclerotic lesion in Apobtm2SgyLdlrtm1Her/J mice: PB 1.32–5
35. Prolonged thromboprophylaxis with low molecular weight heparin to prevent venous thromboembolism after abdominal cancer surgery: a systematic review: PA 1.16–6
36. Effect of immunization of C5a and C3a released from complement component C5 and C3 respectively on early atherosclerotic lesion in Apobtm2SgyLdlrtm1Her/J mouse model: OC 32.6
37. Autoimmune Diseases and Atherosclerosis: The Inflammatory Connection
38. Tissue-selective expression of dominant-negative proteins for the regulation of vascular smooth muscle cell proliferation
39. Design of a muscle cell-specific expression vector utilising human vascular smooth muscle α-actin regulatory elements
40. Therapie tiefer Beinvenenthrombosen mit dem niedermolekularen Heparin Reviparin: Ergebnisse der CORTES-Studie
41. The Role of T-Helper Cells in Atherosclerosis
42. Automorphisms of Zappa-Szép product fixing a subgroup
43. Extended prophylaxis with bemiparin for the prevention of venous thromboembolism after abdominal or pelvic surgery for cancer: the CANBESURE randomized study
44. Late breaking clinical trial: a randomised double blind trial to evaluate the efficacy and safety of prolonging the thromboprophylaxis with bemiparin in patients undergoing cancer abdominal or pelvic surgery (the CANBESURE study): LB-MO-002
45. High antibody levels to pathogens, heat shock proteins and the risk of coronary artery disease in Indian population: OC-TH-118
46. A synergistic role of combination of ApoB and hHSP60 epitopes in regression of atherosclerotic lesion: OC-TU-051
47. Evaluation of sPLA2 type IIa as a marker of coronary artery disease and its predictive value for future coronary events among asian indians: AS-WE-059
48. Pathogenesis and management of delayed orthostatic hypotention in patients with chronic fatigue syndrome
49. Low-Molecular-Weight Heparin versus Warfarin for Prevention of Recurrent Venous Thromboembolism: A Randomized Trial
50. Antithrombotic therapy in patients with chronic heart failure: rationale, clinical evidence and practical implications
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.